Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$136.95 USD

136.95
317,033

+3.11 (2.32%)

Updated Apr 23, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Brokerage Reports

Research for MASI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Masimo Corporation [MASI]

Reports for Purchase

Showing records 361 - 380 ( 481 total )

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 361

10/02/2013

Industry Report

Pages: 9

Healthcare - 3Q 2013: Quarterly Medical Technology Trading & Acquisition Update

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 362

09/30/2013

Industry Report

Pages: 5

Medical Devices - Bill to Repeal Medical Device Tax Gains Increasing Attention

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 363

09/13/2013

Industry Report

Pages: 6

Takeaways from Covidien''s Analyst Meeting

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 364

09/13/2013

Daily Note

Pages: 4

Covidien Comments on MASI Royalty at Analyst Day

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 365

09/10/2013

Industry Report

Pages: 6

Upcoming Covidien Analyst Meeting Could Impact

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 366

08/01/2013

Company Report

Pages: 8

Q2 results inline, guidance unchanged, maintain HOLD

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 367

08/01/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 368

08/01/2013

Company Report

Pages: 8

Solid 2Q - Attractive Risk-Reward; Buy

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 369

07/31/2013

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 370

07/31/2013

Company Report

Pages: 5

Overall Robust 2Q13 Results; Maintain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 371

07/31/2013

Company Report

Pages: 4

2Q13 Preview: Expecting Consistent 2013 Outlook

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 372

07/15/2013

Company Report

Pages: 22

Initiating Coverage with an OUTPERFORM and $28 PT

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 373

07/08/2013

Industry Report

Pages: 6

Healthcare - 2Q 2013: Quarterly Medical Technology Trading & Acquisition Update

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 374

07/02/2013

Daily Note

Pages: 2

Healthcare -Transferring Coverage

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 375

06/10/2013

Company Report

Pages: 8

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 376

05/03/2013

Daily Note

Pages: 4

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 377

05/03/2013

Company Report

Pages: 8

Positive Start to Year, Like the Risk- Reward Profile; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 378

05/03/2013

Company Report

Pages: 8

Q1 results inline, guidance reaffirmed, maintain HOLD, $20.50PT

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 379

05/01/2013

Company Report

Pages: 4

1Q Preview: Looking for More Consistency

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 380

04/18/2013

Company Report

Pages: 8

Price: 24.95